| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 08/01/2013 | US20130196993 N-heteroaryl compounds |
| 08/01/2013 | US20130196989 Compositions and methods for inducing cell dedifferentiation |
| 08/01/2013 | US20130196955 Polymorphisms for predicting disease and treatment outcome |
| 08/01/2013 | US20130196002 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 08/01/2013 | US20130195816 Compositions to effect neuronal growth |
| 07/31/2013 | EP2620430A1 Metal complex, light emitting element, and display device |
| 07/31/2013 | EP2619187A1 Compounds and pharmaceutical compositions for treating disorders associated with the 5-ht1a and 5-ht2a receptors |
| 07/31/2013 | EP2619186A1 Process for preparing pan-cdk inhibitors of the formula (i), and intermediates in the preparation |
| 07/31/2013 | CN103228629A Substituted cyclopentyl -azines as CaSR- active compounds |
| 07/31/2013 | CN103228141A Substituted fused pyrimidinones and dihydropyrimidinones |
| 07/31/2013 | CN103224474A Synthesis of tetracyclines and analogues thereof |
| 07/31/2013 | CN102026970B Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 07/31/2013 | CN101778829B 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides |
| 07/31/2013 | CN101072758B 喹唑啉衍生物 Quinazoline derivatives |
| 07/30/2013 | US8497372 Use of substituted quinazoline compounds in treating age-related macular degeneration |
| 07/30/2013 | US8497369 Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production |
| 07/30/2013 | US8497064 Nucleic acid labelling compounds |
| 07/30/2013 | CA2575472C Hiv inhibiting 5-substituted pyrimidines |
| 07/25/2013 | WO2013040227A3 Therapeutic compounds |
| 07/25/2013 | WO2012176218A8 Process for preparing rosuvastatin calcium through novel amine salt |
| 07/25/2013 | US20130190488 Apoptosis promoters |
| 07/25/2013 | US20130190371 Fungicide Active Substance Combinations |
| 07/25/2013 | US20130190340 Small-Molecule-Targeted Protein Degradation |
| 07/25/2013 | US20130190325 Compounds for treating proliferative disorders |
| 07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 07/24/2013 | EP2618219A1 Charge control agent and toner using same |
| 07/24/2013 | EP2617717A1 P2x4 receptor antagonist |
| 07/24/2013 | EP2617435A1 Therapeutic agents and prophylactic agents for symptoms accompanying autoimmune diseases, inflammatory diseases, allergy diseases and organ transplants |
| 07/24/2013 | CN1980899B Quinazolinone derivatives as parp inhibitors |
| 07/24/2013 | CN1863800B Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/24/2013 | CN103214423A Preparation method of acrylate compound |
| 07/24/2013 | CN103214413A Heterocycle-containing trifluoromethyl ketone compound and preparation method thereof |
| 07/24/2013 | CN103214409A Synthesis of tetracyclines and analogues thereof |
| 07/24/2013 | CN103214337A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN102219751B Pentadienone-containing 4-substituted quinazoline derivative, preparation method and use thereof |
| 07/24/2013 | CN101885722B Heterocycle alkyne and benzene compound, medicinal composition and application thereof |
| 07/24/2013 | CN101212903B Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity |
| 07/24/2013 | CN101128199B Monocyclic heterocycles as kinase inhibitors |
| 07/24/2013 | CN101111484B Process for the manufacture of a precursor of vitamin B1 |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492543 Method for producing quinazoline derivative |
| 07/23/2013 | US8492542 Method for producing bicyclic guanidines by use of a cyclic thiourea |
| 07/23/2013 | US8492394 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl-thiomorpholin-4-yl) derivatives of 6,7-dialkoxy-quinazoline, 6,7-dialkoxyphtalazine and 6,7-dialkoxyisoquinoline as PDE10A enzyme inhibitors |
| 07/23/2013 | US8492390 Synthesis of locked nucleic acid derivatives |
| 07/23/2013 | US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists |
| 07/23/2013 | US8492365 7-substituted tetracycline compounds |
| 07/23/2013 | CA2712819C Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same |
| 07/23/2013 | CA2583967C 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/23/2013 | CA2534675C Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 07/18/2013 | WO2013106792A1 Heterocyclic compounds and uses as anticancer agents. |
| 07/18/2013 | WO2013070852A3 Compounds and compositions used to epigenetically transform cells and methods related thereto |
| 07/18/2013 | WO2013048949A3 Selective nr2b antagonists |
| 07/18/2013 | US20130184459 P2x4 receptor antagonist |
| 07/18/2013 | US20130184286 Compounds and pharmaceutical compositions for treating disorders associated with the 5-ht1a and 5-ht2a receptors |
| 07/18/2013 | US20130184279 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| 07/18/2013 | US20130184263 Derivatives of Betulin |
| 07/18/2013 | US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 07/17/2013 | EP2615087A2 Phenylalanine derivatives |
| 07/17/2013 | EP2615086A1 2,4-Diaminoquinazolines for the treatment of spinal muscular atrophy |
| 07/17/2013 | EP2614822A2 Atorvastatin Derivatives |
| 07/17/2013 | EP2614054A1 Ethyne derivatives, pharmaceutical compositions and uses thereof |
| 07/17/2013 | EP2613775A1 Novel n-hydroxy-benzamides for the treatment of cancer |
| 07/17/2013 | CN103209961A Process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives |
| 07/17/2013 | CN103209960A Sulfonamide compounds useful as CYP17 inhibitors |
| 07/17/2013 | CN103204818A Preparation method of multi-substituted quinazoline derivative |
| 07/17/2013 | CN103204817A Preparation method for 4-cyanoquinoline derivatives |
| 07/17/2013 | CN103204816A Piperazinyl pyrimidine derivative, and preparation method and application thereof |
| 07/17/2013 | CN103204815A 4-(4-cyano-2-thioaryl)dihydropyrimidinones And Use Thereof |
| 07/17/2013 | CN103204814A Preparation method of nifedipine as well as impurity separating method and application of nifedipine |
| 07/17/2013 | CN102219749B Method for preparing rosuvastatin calcium |
| 07/17/2013 | CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
| 07/17/2013 | CN101641339B Compounds for the prevention and treatment of cardiovascular diseases |
| 07/17/2013 | CN101415683B New compounds |
| 07/17/2013 | CN101248051B Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile |
| 07/17/2013 | CN101248050B Organic compounds |
| 07/16/2013 | US8487097 Reference standard for characterization of rosuvastatin |
| 07/16/2013 | US8486955 Anti-cancer cyclopenta [g] quinazoline compounds |
| 07/16/2013 | US8486952 Compounds for the reduction of β-amyloid production |
| 07/16/2013 | US8486951 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | CA2705474C O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 07/16/2013 | CA2569826C Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 07/11/2013 | WO2013102655A1 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b |
| 07/11/2013 | US20130178631 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 07/11/2013 | US20130178624 Quinazoline derivatives |
| 07/11/2013 | US20130178462 Compounds for the reduction of beta-amyloid production |
| 07/11/2013 | US20130178420 Novel glp-1 receptor modulators |
| 07/10/2013 | EP2612862A2 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/10/2013 | EP2612860A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof |
| 07/10/2013 | EP2612855A1 Novel crystal of erlotinib base and the preparation method thereof |
| 07/10/2013 | EP2612854A1 Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors |
| 07/10/2013 | EP2612852A1 Theramutein modulators |
| 07/10/2013 | EP2611797A2 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells |
| 07/10/2013 | EP2611771A1 New compounds, pharmaceutical compositions and uses thereof |
| 07/10/2013 | EP2611300A1 Substituted fused pyrimidinones and dihydropyrimidinones |
| 07/10/2013 | CN103201270A P2x4 receptor antagonist |
| 07/10/2013 | CN103200936A Novel n-hydroxy-benzamides for the treatment of cancer |
| 07/10/2013 | CN103193911A Amino arene structure unit-containing polyacrylate functionalized polymer and preparation method thereof |
| 07/10/2013 | CN103193722A Novel quinazoline nitrogen mustard compound, and preparation method and application thereof to treatment of cancer |
| 07/10/2013 | CN103193721A Heat stabilizer composition used for PVC, ketone compound and application of ketone compound |